|
US3472859A
(en)
|
1966-11-01 |
1969-10-14 |
Sterling Drug Inc |
1-alkyl-1,4-dihydro-4-oxo-3 quinoline-carboxylic acids and esters
|
|
JPS4826772Y1
(enExample)
|
1969-04-04 |
1973-08-06 |
|
|
|
ATE27451T1
(de)
|
1981-03-24 |
1987-06-15 |
Ciba Geigy Ag |
Acyl-chinolinonderivate, verfahren zu ihrer herstellung, diese enthaltende pharmazeutische praeparate und ihre verwendung.
|
|
US4910327A
(en)
|
1982-05-25 |
1990-03-20 |
American Cyanamid Company |
Alkyl esters of substituted 2-methyl-3-quinolinecarboxylic acid and quinoline-2,3-dicarboxylic acid: dialkyl 3-(substituted)phenylaminobut-2-ene-dioates and methods for the preparation thereof
|
|
US4656283A
(en)
|
1982-05-25 |
1987-04-07 |
American Cyanamid Company |
Alkyl esters of substituted 2-methyl-3-quinolinecarboxylic acid and quinoline-2,3-dicarboxylic acid
|
|
PT79699B
(en)
|
1983-12-22 |
1986-12-10 |
Pfizer |
Process for preparing quinolone inotropic agents
|
|
FR2634483B2
(fr)
|
1987-12-29 |
1994-03-04 |
Esteve Labor Dr |
Derives des acides 7-(1-azetidinyl)-1,4-dihydro-4-oxoquinoleine-3-carboxyliques, leur preparation et leur application en tant que medicaments
|
|
CA2002864C
(en)
|
1988-11-29 |
1999-11-16 |
Eddy J. E. Freyne |
(1h-azol-1-ylmethyl) substituted quinoline, quinazoline or quinoxaline derivatives
|
|
WO1992020642A1
(en)
|
1991-05-10 |
1992-11-26 |
Rhone-Poulenc Rorer International (Holdings) Inc. |
Bis mono-and bicyclic aryl and heteroaryl compounds which inhibit egf and/or pdgf receptor tyrosine kinase
|
|
US5478832A
(en)
|
1992-05-08 |
1995-12-26 |
The Green Cross Corporation |
Quinoline compounds
|
|
JPH0826772A
(ja)
|
1994-07-22 |
1996-01-30 |
Sony Corp |
融着用ガラス、その製造方法及び製造装置、並びに磁気ヘッドの製造方法
|
|
DE69512495T2
(de)
|
1994-10-27 |
2000-02-03 |
Asahi Glass Co. Ltd., Tokio/Tokyo |
Verfahren zur Herstellung von Chinolin-2-yl-benzoesäure
|
|
GB9523267D0
(en)
|
1995-11-14 |
1996-01-17 |
Sandoz Ltd |
Organic compounds
|
|
EA000710B1
(ru)
|
1995-12-08 |
2000-02-28 |
Жансен Фармасетика Н.В. |
(имидазол-5-ил)метил-2-хинолиноновые производные, ингибирующие фарнезилпротеин-трансферазу
|
|
EP0901489A1
(en)
|
1996-05-20 |
1999-03-17 |
Merck & Co., Inc. |
Antagonists of gonadotropin releasing hormone
|
|
EP0988038B1
(en)
|
1997-06-02 |
2002-08-14 |
Janssen Pharmaceutica N.V. |
(imidazol-5-yl)methyl-2-quinolinone derivatives as inhibitors of smooth muscle cell proliferation
|
|
RU2220960C2
(ru)
|
1997-12-22 |
2004-01-10 |
Фармация Энд Апджон Компани |
4-гидрокси-3-хинолинкарбоксамиды и гидразиды, фармацевтическая композиция и способ лечения на их основе
|
|
FR2776388B1
(fr)
|
1998-03-20 |
2006-04-28 |
Lipha |
Utilisation de recepteurs de la famille ror pour le criblage de substances utiles pour le traitement de l'atherosclerose
|
|
US6399629B1
(en)
|
1998-06-01 |
2002-06-04 |
Microcide Pharmaceuticals, Inc. |
Efflux pump inhibitors
|
|
HRP20000904A2
(en)
*
|
1998-07-06 |
2001-12-31 |
Janssen Pharmaceutica Nv |
Farnesyl protein transferase inhibitors for treating arthropathies
|
|
PT1094839E
(pt)
|
1998-07-06 |
2003-09-30 |
Janssen Pharmaceutica Nv |
Inibidores da proteina farnesil transferase com propriedades de radiossensibilizacao (in vivo)
|
|
JP2000169451A
(ja)
|
1998-09-30 |
2000-06-20 |
Kyorin Pharmaceut Co Ltd |
６，７―ジ置換キノリンカルボン酸誘導体とその付加塩及びそれらの製造方法
|
|
ES2200591T3
(es)
|
1998-12-23 |
2004-03-01 |
Janssen Pharmaceutica N.V. |
Derivados de 1,2-quinolina anelados.
|
|
US6248736B1
(en)
|
1999-01-08 |
2001-06-19 |
Pharmacia & Upjohn Company |
4-oxo-1,4-dihydro-3-quinolinecarboxamides as antiviral agents
|
|
US6248739B1
(en)
|
1999-01-08 |
2001-06-19 |
Pharmacia & Upjohn Company |
Quinolinecarboxamides as antiviral agents
|
|
CN1340051A
(zh)
|
1999-02-11 |
2002-03-13 |
辉瑞产品公司 |
可用作抗癌剂的杂芳基取代的喹啉－2－酮衍生物
|
|
TR200400342T4
(tr)
|
1999-11-30 |
2004-03-22 |
Pfizer Products Inc. |
Farnezil protein transferazı önlemek için kinolin türevleri.
|
|
SI1255537T1
(sl)
|
2000-02-04 |
2006-10-31 |
Janssen Pharmaceutica Nv |
Inhibitorji farnezil protein transferaze za zdravljenje raka dojk
|
|
ATE375794T1
(de)
|
2000-02-24 |
2007-11-15 |
Janssen Pharmaceutica Nv |
Dosierschema enthaldend farnesyl protein transferase inhibitoren für die behandlung von krebs
|
|
JP2003525237A
(ja)
|
2000-02-29 |
2003-08-26 |
ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ |
抗腫瘍性アントラサイクリン誘導体とのファルネシルタンパク質トランスフェラーゼ阻害剤組み合わせ剤
|
|
WO2001064217A2
(en)
|
2000-02-29 |
2001-09-07 |
Janssen Pharmaceutica N.V. |
Combinations of a farnesyl protein transferase inhibitor with nitrogen mustard or nitrosourea alkylating agents
|
|
CA2397690A1
(en)
|
2000-02-29 |
2001-09-07 |
Janssen Pharmaceutica N.V. |
Farnesyl protein transferase inhibitor combinations with anti-tumor nucleoside derivatives
|
|
EP1267871A2
(en)
|
2000-02-29 |
2003-01-02 |
Janssen Pharmaceutica N.V. |
Farnesyl protein transferase inhibitor combinations with anti-tumor podophyllotoxin derivatives
|
|
US20030125326A1
(en)
|
2000-02-29 |
2003-07-03 |
Rybak Mary Ellen Margaret |
Farnesyl protein transferase inhibitor combinations
|
|
JP2003525255A
(ja)
|
2000-02-29 |
2003-08-26 |
ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ |
ファルネシルタンパク質トランスフェラーゼ阻害剤とさらなる抗癌剤との組み合わせ剤
|
|
AU2001246477A1
(en)
|
2000-02-29 |
2001-09-12 |
Janssen Pharmaceutica N.V. |
Farnesyl protein transferase inhibitor combinations with platinum compounds
|
|
CA2397240A1
(en)
|
2000-02-29 |
2001-09-07 |
Peter Albert Palmer |
Farnesyl protein transferase inhibitor combinations with camptothecin compounds
|
|
US20030022918A1
(en)
|
2000-02-29 |
2003-01-30 |
Horak Ivan David |
Farnesyl protein transferase inhibitor combinations with an her2 antibody
|
|
JP2003525236A
(ja)
|
2000-02-29 |
2003-08-26 |
ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ |
ビンカアルカロイドとのファルネシルタンパク質トランスフェラーゼ阻害剤の組み合わせ剤
|
|
JP2003525239A
(ja)
|
2000-02-29 |
2003-08-26 |
ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ |
タキサン化合物とのファルネシルタンパク質トランスフェラーゼ阻害剤の組み合わせ剤
|
|
US6844357B2
(en)
|
2000-05-01 |
2005-01-18 |
Pfizer Inc. |
Substituted quinolin-2-one derivatives useful as antiproliferative agents
|
|
US6525049B2
(en)
|
2000-07-05 |
2003-02-25 |
Pharmacia & Upjohn Company |
Pyrroloquinolones as antiviral agents
|
|
US6624159B2
(en)
|
2000-07-12 |
2003-09-23 |
Pharmacia & Upjohn Company |
Heterocycle carboxamides as antiviral agents
|
|
AU2001269704A1
(en)
|
2000-07-12 |
2002-01-21 |
Pharmacia And Upjohn Company |
Oxazinoquinolones useful for the treatment of viral infections
|
|
WO2002024686A2
(en)
|
2000-09-25 |
2002-03-28 |
Janssen Pharmaceutica N.V. |
Farnesyl transferase inhibiting 6-heterocyclylmethyl quinoline and quinazoline derivatives
|
|
EP1322635B1
(en)
|
2000-09-25 |
2006-03-22 |
Janssen Pharmaceutica N.V. |
Farnesyl transferase inhibiting quinoline and quinazoline derivatives as farnesyl transferase inhibitors
|
|
WO2002024687A1
(en)
|
2000-09-25 |
2002-03-28 |
Janssen Pharmaceutica N.V. |
Farnesyl transferase inhibiting 6-heterocyclylmethyl quinolinone derivatives
|
|
AU9384701A
(en)
|
2000-10-02 |
2002-04-15 |
Janssen Pharmaceutica Nv |
Metabotropic glutamate receptor antagonists
|
|
US20040044032A1
(en)
|
2000-11-28 |
2004-03-04 |
End David William |
Farnesyl protein transfer inhibitors for the treatment of inflammatory bowel disease
|
|
JP4351445B2
(ja)
|
2000-12-27 |
2009-10-28 |
ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ |
ファルネシルトランスフェラーゼを阻害する４−置換−キノリンおよびキナゾリン誘導体
|
|
WO2002064142A1
(en)
|
2001-02-15 |
2002-08-22 |
Janssen Pharmaceutica N.V. |
Farnesyl protein transferase inhibitor combinations with antiestrogen agents
|
|
WO2002070487A1
(en)
|
2001-03-01 |
2002-09-12 |
Pharmacia & Upjohn Company |
Substituted quinolinecarboxamides as antiviral agents
|
|
US20040157773A1
(en)
|
2001-04-25 |
2004-08-12 |
End David William |
Farnesyl protein transferase inhibitors for treating cachexia
|
|
WO2003000705A1
(en)
|
2001-06-21 |
2003-01-03 |
Ariad Pharmaceuticals, Inc. |
Novel quinolines and uses thereof
|
|
MXPA04006041A
(es)
|
2001-12-20 |
2004-09-27 |
Upjohn Co |
Antivirales de piridoquinoxalina.
|
|
US6686356B2
(en)
|
2001-12-20 |
2004-02-03 |
Pharmacia & Upjohn Company |
Pyridoquinoxaline antivirals
|
|
JP4573533B2
(ja)
|
2002-03-29 |
2010-11-04 |
ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ |
放射能標識付きキノリンおよびキノリノン誘導体および代謝向性グルタメート受容体リガンドとしてのそれらの使用
|
|
JP3908248B2
(ja)
|
2002-08-13 |
2007-04-25 |
塩野義製薬株式会社 |
Ｈｉｖインテグラーゼ阻害活性を有するヘテロ環化合物
|
|
AU2003262947A1
(en)
|
2002-08-30 |
2004-03-19 |
Pharmacia And Upjohn Company |
Method of preventing or treating atherosclerosis or restenosis
|
|
GB0222516D0
(en)
|
2002-09-27 |
2002-11-06 |
Karobio Ab |
Novel compounds
|
|
AR045697A1
(es)
|
2003-07-14 |
2005-11-09 |
Arena Pharm Inc |
Aril y heteroaril derivados fusionados como moduladores del metabolismo y la prevencion y tratamiento de trastornos relacionados con el mismo
|
|
KR101118582B1
(ko)
|
2003-11-20 |
2012-02-27 |
얀센 파마슈티카 엔.브이. |
폴리(ａｄｐ-리보스)폴리머라제 저해제로서의 6-알케닐 및6-페닐알킬 치환된 2-퀴놀리논 및 2-퀴녹살리논
|
|
CA2546657C
(en)
|
2003-12-05 |
2013-05-14 |
Janssen Pharmaceutica N.V. |
6-substituted 2-quinolinones and 2-quinoxalinones as poly(adp-ribose) polymerase inhibitors
|
|
JP4948178B2
(ja)
|
2003-12-10 |
2012-06-06 |
ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ |
ポリ（ａｄｐ−リボース）ポリメラーゼ阻害剤としての置換６−シクロヘキシルアルキル置換２−キノリノンおよび２−キノキサリノン
|
|
AU2004298486A1
(en)
|
2003-12-12 |
2005-06-30 |
Wyeth |
Quinolines useful in treating cardiovascular disease
|
|
US7902225B2
(en)
|
2004-01-23 |
2011-03-08 |
Janssen Pharmaceutica Nv |
Mycobacterial inhibitors
|
|
EP1713776B1
(en)
|
2004-01-29 |
2008-05-14 |
Janssen Pharmaceutica N.V. |
Quinoline derivatives for use as mycobacterial inhibitors
|
|
JP2005225250A
(ja)
|
2004-02-10 |
2005-08-25 |
Murakami Corp |
車載用監視装置
|
|
EA012837B1
(ru)
|
2004-06-30 |
2009-12-30 |
Янссен Фармацевтика Н.В. |
Производные хиназолинона в качестве ингибиторов parp
|
|
BRPI0514051B1
(pt)
|
2004-08-04 |
2014-07-22 |
Nippon Kayaku Co. , Ltd. |
Composto derivado de quinolina que compreende o mesmo como ingrediente ativo, inseticida, método e uso destes no controle de pragas de insetos na agricultura e horticultura
|
|
KR100686531B1
(ko)
|
2004-08-31 |
2007-02-23 |
한국화학연구원 |
히스톤 디아세틸라제 저해활성을 갖는 아릴아미노메틸프로페닐 벤즈하이드록시아마이드 유도체 및 그의 제조방법
|
|
EP2362218B1
(en)
|
2004-11-05 |
2014-08-27 |
Janssen Pharmaceutica N.V. |
Methods of monitoring the efficacy of farnesyltransferase inhibitors
|
|
JO2855B1
(en)
|
2005-08-03 |
2015-03-15 |
شركة جانسين فارماسوتيكا ان. في |
Quinoline derivatives acting as antibacterial agents
|
|
JO2952B1
(en)
|
2005-08-03 |
2016-03-15 |
جانسين فارماسوتيكا ان. في |
Quinoline derivatives acting as antibacterial agents
|
|
JP5112083B2
(ja)
|
2006-02-03 |
2013-01-09 |
Ｍｅｉｊｉ Ｓｅｉｋａファルマ株式会社 |
新規キノリン誘導体およびこれを有効成分として含有する農園芸用殺菌剤
|
|
US8389739B1
(en)
|
2006-10-05 |
2013-03-05 |
Orphagen Pharmaceuticals |
Modulators of retinoid-related orphan receptor gamma
|
|
AU2007309237B2
(en)
|
2006-10-23 |
2012-03-22 |
Sgx Pharmaceuticals, Inc. |
Triazolo-pyridazine protein kinase modulators
|
|
JO3271B1
(ar)
|
2006-12-06 |
2018-09-16 |
Janssen Pharmaceutica Nv |
مشتقات الكوينولين المضادة للجراثيم
|
|
AR065093A1
(es)
|
2007-02-05 |
2009-05-13 |
Merck Frosst Canada Ltd |
Compuestos farmacéuticos inhibidores de la biosintesis de leucotrienos
|
|
UY30892A1
(es)
|
2007-02-07 |
2008-09-02 |
Smithkline Beckman Corp |
Inhibidores de la actividad akt
|
|
WO2008112525A2
(en)
|
2007-03-09 |
2008-09-18 |
Link Medicine Corporation |
Treatment of lysosomal storage diseases
|
|
CN101678014B
(zh)
|
2007-05-21 |
2012-12-12 |
Sgx药品公司 |
杂环激酶调节剂
|
|
CN101143845B
(zh)
|
2007-10-15 |
2010-08-25 |
中国药科大学 |
取代喹啉甲酰胍衍生物、其制备方法及其医药用途
|
|
EP2250153B1
(en)
|
2008-01-18 |
2013-06-19 |
Allergan, Inc. |
Substituted-aryl-(imidazole)-methyl)-phenyl compounds as subtype selective modulators of alpha 2b and/or alpha 2c adrenergic receptors
|
|
EP2265600A1
(en)
|
2008-02-05 |
2010-12-29 |
Pfizer Inc. |
Pyridinyl amides for the treatment of cns and metabolic disorders
|
|
US20090286829A1
(en)
|
2008-05-13 |
2009-11-19 |
Allergan, Inc. |
Quinolynylmethylimidizoles as therapeutic agents
|
|
WO2010068296A1
(en)
|
2008-12-11 |
2010-06-17 |
Stiefel Laboratories, Inc. |
Piperazine carboxamidines as antimicrobial agents
|
|
WO2010127208A1
(en)
|
2009-04-30 |
2010-11-04 |
Forest Laboratories Holdings Limited |
Inhibitors of acetyl-coa carboxylase
|
|
CN101899011B
(zh)
|
2009-05-26 |
2013-01-16 |
北京大学 |
氨基二硫代甲酸酯类化合物、其制备方法和应用
|
|
TWI428332B
(zh)
|
2009-06-09 |
2014-03-01 |
Hoffmann La Roche |
雜環抗病毒化合物
|
|
SG176986A1
(en)
|
2009-06-25 |
2012-02-28 |
Amgen Inc |
Polycyclic derivatives of pyridine and their use in the treatment of (inter alia) rheumatoid arthritis and similar diseases
|
|
KR20120089463A
(ko)
|
2009-08-20 |
2012-08-10 |
노파르티스 아게 |
헤테로시클릭 옥심 화합물
|
|
EP2368886A1
(en)
|
2010-03-01 |
2011-09-28 |
Phenex Pharmaceuticals AG |
Novel compounds for modulation of orphan nuclear receptor RAR-related orphan receptor-gamma (ROR gamma, NR1F3) activity and for the treatment of chronic inflammatory and autoimmune desease
|
|
WO2011112264A1
(en)
|
2010-03-11 |
2011-09-15 |
New York University |
Compounds as rorϒt modulators and uses thereof
|
|
MX2012011996A
(es)
|
2010-04-15 |
2013-11-27 |
Chromocell Corp |
Compuestos , composiciones y metodos para reducir o eliminar el sabor amargo.
|
|
CA2816753A1
(en)
*
|
2010-11-08 |
2012-05-18 |
Lycera Corporation |
N- sulfonylated tetrahydroquinolines and related bicyclic compounds inhibition of rory activity and the treatment of diseases
|
|
US11179500B2
(en)
|
2011-02-24 |
2021-11-23 |
Emory University |
JAB1 inhibitory compositions for ossification and methods related thereto
|
|
TWI532728B
(zh)
|
2011-04-28 |
2016-05-11 |
日本煙草產業股份有限公司 |
醯胺化合物及其醫藥用途
|
|
US9586928B2
(en)
|
2011-05-16 |
2017-03-07 |
The Scripps Research Institute |
Modulators of the nuclear hormone receptor ROR
|
|
GB201118652D0
(en)
|
2011-10-28 |
2011-12-07 |
Astex Therapeutics Ltd |
New compounds
|
|
WO2013064231A1
(en)
|
2011-10-31 |
2013-05-10 |
Phenex Pharmaceuticals Ag |
SEVEN-MEMBERED SULFONAMIDES AS MODULATORS OF RAR-RELATED ORPHAN RECEPTOR-GAMMA (RORγ, NR1F3)
|
|
CA2856946C
(en)
|
2011-12-02 |
2016-08-02 |
Phenex Pharmaceuticals Ag |
Pyrrolo carboxamides as modulators of orphan nuclear receptor rar-related orphan receptor-gamma (rory, nr1f3) activity and for the treatment of chronic inflammatory and autoimmunediseases
|